Mainstream

Icon signals $8B full-year revenue midpoint as metabolic and obesity trial momentum builds

Icon signals $8B full-year revenue midpoint as metabolic and obesity trial momentum builds

Post ContenticlrRead More

You might also be interested in reading Bitcoin miner Canaan’s net loss slightly improved in Q1 amid market turbulence.

July 24, 2025
In Mainstream